12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several health care stocks experienced significant price movements. Notable gainers included Tevogen Bio Holdings, CNS Pharma, and DBV Technologies, while Conduit Pharmaceuticals, Genprex, and Ensysce Biosciences were among the losers.
October 24, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Conduit Pharmaceuticals shares fell by 16.8% in pre-market trading, indicating negative investor sentiment.
The significant decrease in CDT's stock price suggests negative sentiment or news, likely leading to a short-term price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Ensysce Biosciences shares declined by 13.56% in pre-market trading, suggesting negative investor sentiment.
The drop in ENSC's stock price indicates negative market sentiment, likely resulting in a short-term price decrease.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Genprex stock decreased by 13.59% in pre-market trading, reflecting negative market sentiment.
GNPX's stock price decline indicates negative investor sentiment, likely leading to a short-term price decrease.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
CNS Pharma shares rose by 24.11% in pre-market trading, reflecting positive market sentiment.
CNSP's stock price increase indicates positive investor sentiment, likely leading to a short-term price rise.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
DBV Technologies stock increased by 21.51% in pre-market trading, suggesting strong investor interest.
The rise in DBVT's stock price indicates positive market sentiment, likely resulting in a short-term price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Tevogen Bio Holdings shares surged by 27.4% in pre-market trading, indicating strong investor interest.
The significant increase in TVGN's stock price suggests positive sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90